Neurological disorders affect millions of people annually at a tremendous social and economic cost. As many neurological disorders are chronic conditions resulting in long-term disability or suffering, early and accurate diagnosis is of the utmost importance.
The development of clinical diagnostics for many neurodegenerative and neuropsychiatric conditions has been challenging since the molecular basis of these diseases are ill-defined or unknown. Recent advances in the identification of biomarkers for neurological disorders are providing researchers and clinicians with powerful new tools to improve diagnosis and therapeutics.
- 21 Jul 2015
- Application Notes, Neuroscience